Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Price:
8.24
USD
-2.25%
Market Closed
Market Cap:
$141.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
|
US |
|
Emerita Resources Corp
XTSX:EMO
|
CA |
|
Gateley (Holdings) PLC
F:5I2
|
UK |
|
C
|
Carter's Inc
SWB:HCH
|
US |
|
Palantir Technologies Inc
LSE:0A7R
|
US |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
Credit Agricole SA
PAR:ACA
|
FR |
|
Volvo AB
OTC:VOLAF
|
SE |
|
Z
|
Zurich Insurance Group AG
XBER:ZFI1
|
CH |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
O
|
Owens Corning
F:O5Q
|
US |
|
D
|
Dongfang Electric Corp Ltd
XBER:DEU
|
CN |
|
C
|
Canopy Growth Corp
NASDAQ:CGC
|
CA |
Wall St Price Targets
VRCA Price Targets Summary
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
Wall Street analysts forecast VRCA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for VRCA is 16.83 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.
Lowest Forecast
Price Target
10.1
USD
23% Upside
Average Forecast
Price Target
16.83
USD
104% Upside
Highest Forecast
Price Target
21
USD
155% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRCA's stock price target?
Price Target
16.83
USD
16.83
USD
According to Wall Street analysts, the average 1-year price target for VRCA is 16.83 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.
What is the Revenue forecast for Verrica Pharmaceuticals Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Revenue over the next 8 years is 31%.
